Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 12,780.00p on 07-10-2025 at 18:50:05
Change 54.00p 0.42%
Buy 12,774.00p
Sell 12,768.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 272.00 at 12,703.33832p
Day's Volume: 1,597,144
Last Close: 12,780.00p
Open: 12,700.00p
ISIN: GB0009895292
Day's Range 12,676.00p - 12,830.00p
52wk Range: 9,574.00p - 12,866.00p
Market Capitalisation: £198.12b
VWAP: 12,755.02401p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 272 12,703.33832p Currency Conversion
Negotiated Trade
OTC Trade
 17:33:19 - 07-Oct-25
Buy* 98,889 12,776.01p SI Trade
Negotiated Trade
 17:23:56 - 07-Oct-25
Buy* 44 12,776.01p SI Trade
Negotiated Trade
 17:23:56 - 07-Oct-25
Buy* 3,408 12,776.01p SI Trade
Negotiated Trade
 17:23:56 - 07-Oct-25
Buy* 10 12,776.01p SI Trade
Negotiated Trade
 17:23:56 - 07-Oct-25
Buy* 800 12,776.01p SI Trade
Negotiated Trade
 17:23:55 - 07-Oct-25
Buy* 367 12,780.00p SI Trade
Negotiated Trade
 17:22:25 - 07-Oct-25
Buy* 2,078 12,780.00p SI Trade
Negotiated Trade
 17:22:25 - 07-Oct-25
Buy* 1,644 12,780.00p SI Trade
Negotiated Trade
 17:22:25 - 07-Oct-25
Buy* 2,913 12,780.00p SI Trade
Negotiated Trade
 17:22:25 - 07-Oct-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
7th Oct 2025 (Tue) 12,700.00 12,830.00 12,676.00 12,780.00 1,597,144
6th Oct 2025 (Mon) 12,716.00 12,866.00 12,687.00 12,726.00 2,970,312
3rd Oct 2025 (Fri) 12,452.00 12,650.00 12,412.00 12,650.00 2,234,256
2nd Oct 2025 (Thu) 12,720.00 12,750.00 12,356.00 12,454.00 3,205,033
1st Oct 2025 (Wed) 11,488.00 12,462.00 11,476.00 12,436.00 4,371,301
30th Sep 2025 (Tue) 11,034.00 11,258.00 10,922.00 11,182.00 2,361,402
29th Sep 2025 (Mon) 11,050.00 11,186.00 10,976.00 11,088.00 2,264,454
26th Sep 2025 (Fri) 10,900.00 11,018.00 10,784.00 11,000.00 1,551,980
25th Sep 2025 (Thu) 11,164.00 11,184.00 10,956.00 10,956.00 1,788,667
24th Sep 2025 (Wed) 11,198.00 11,242.00 11,104.00 11,210.00 1,431,143
23rd Sep 2025 (Tue) 11,432.00 11,446.00 11,250.00 11,258.00 1,476,753
22nd Sep 2025 (Mon) 11,282.00 11,514.00 11,248.00 11,500.00 1,463,010
19th Sep 2025 (Fri) 11,382.00 11,444.00 11,288.00 11,304.00 4,376,766
18th Sep 2025 (Thu) 11,424.00 11,448.00 11,224.00 11,248.00 2,290,527
17th Sep 2025 (Wed) 11,338.00 11,400.00 11,246.00 11,396.00 1,404,238
16th Sep 2025 (Tue) 11,400.00 11,502.00 11,332.00 11,346.00 4,005,150
15th Sep 2025 (Mon) 11,656.00 11,690.00 11,340.00 11,414.00 3,189,408
12th Sep 2025 (Fri) 11,930.00 11,986.00 11,772.00 11,794.00 1,924,992
11th Sep 2025 (Thu) 11,936.00 12,002.00 11,894.00 11,956.00 1,267,305
10th Sep 2025 (Wed) 12,008.00 12,062.00 11,912.00 11,914.00 1,129,376
9th Sep 2025 (Tue) 11,998.00 12,010.00 11,888.00 11,976.00 983,718
8th Sep 2025 (Mon) 12,130.00 12,130.00 11,840.00 11,970.00 1,167,793
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
7th Oct 2025 7:00 am RNS Baxdrostat met primary endpoint in Bax24 Ph3 trial
6th Oct 2025 7:30 am RNS Datroway improved OS and PFS in TROPION-Breast02
1st Oct 2025 3:00 pm RNS Total Voting Rights
29th Sep 2025 7:30 am RNS Enhertu improved IDFS in early BC in DB-05
29th Sep 2025 7:00 am RNS AZN harmonises listing structure
25th Sep 2025 4:30 pm RNS Director/PDMR Shareholding
22nd Sep 2025 7:05 am RNS Koselugo recommended for EU approval
22nd Sep 2025 7:00 am RNS Tezspire Recommended for Approval in EU for CRSwNP
17th Sep 2025 7:05 am RNS Saphnelo met primary endpoint in TULIP-SC
17th Sep 2025 7:00 am RNS Update on RESOLUTE Phase III trial
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca touts positive results in trial for hypertension therapy

7th Oct 2025 08:40

(Alliance News) - AstraZeneca PLC on Tuesday said its therapy for hypertension demonstrated positive results in a recent phase 3 trial, while its breast cancer therapy is put forward for review in Japan. Read More

LONDON MARKET MIDDAY: UK construction confidence remains weak

6th Oct 2025 12:01

(Alliance News) - Stock prices in London were mostly lower at midday on Monday, while data published by S&P Global showed that the UK construction sector's decline slowed in September. Read More

PRESS: AstraZeneca signs USD555 million AI gene-editing deal – FT

6th Oct 2025 10:52

(Alliance News) - AstraZeneca PLC has signed a USD555 million deal with San Francisco-based Algen Biotechnologies to develop gene-editing therapies using artificial intelligence, the Financial Times reported on Monday. Read More

LONDON MARKET OPEN: FTSE 100 red as Mondi warns on trading climate

6th Oct 2025 09:08

(Alliance News) - Stock prices in London opened mostly lower on Monday, while in the Middle East ceasefire talks are due to start between Israel and Hamas. Read More

AstraZeneca, Daiichi drug boosts survival in aggressive breast cancer

6th Oct 2025 08:19

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said their drug Datroway significantly improved survival outcomes for patients with a hard-to-treat form of breast cancer, marking a potential advance in treatment options. Read More

See more Astrazeneca news
FTSE 100 Latest
Value9,483.58
Change4.44

Login to your account

Forgot Password?

Not Registered